Rajiv Gupta

Rajiv Gupta

Auto-generated profile, based on publicly available information

Rajiv Gupta

Department of Neuroradiology, Massachusetts General Hospital, Boston, MA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
FMFarhad Maleki
Farhad Maleki
KOKatie Ovens
Katie Ovens
RGRajiv Gupta
Rajiv Gupta
CRCaroline Reinhold
Caroline Reinhold
Alan SpatzAlan Spatz
Alan Spatz
RFReza Forghani
Reza Forghani
“Just Accepted” papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review ...

1 March 2025 in Radiology
Verified
Journal Article
Closed access
FSFides Regina Schwartz
Fides Regina Schwartz
ASAaron D. Sodickson
Aaron D. Sodickson
PPPerry J. Pickhardt
Perry J. Pickhardt
DSDushyant V. Sahani
Dushyant V. Sahani
MLMichael H. Lev
Michael H. Lev
RGRajiv Gupta
Rajiv Gupta
This comprehensive, state-of-the-art review focuses on foundational principles, technical implementation, current practice, and potential future clinical applications of photon-counting CT technology.

18 March 2021 in Blood
Verified
Journal Article
Open access
PDF file
MGMihir Gupta
Mihir Gupta
EBEvan J. Burns
Evan J. Burns
NGNicholas Z. Georgantas
Nicholas Z. Georgantas
JTJulia Thierauf
Julia Thierauf
NNNaema Nayyar
Naema Nayyar
GSGanesh M. Shankar
Ganesh M. Shankar
Diagnosing primary central nervous system lymphoma (PCNSL) frequently requires neurosurgical biopsy due to nonspecific radiologic features and the low yield of cerebrospinal fluid (CSF) studies. We characterized the clinical evaluation of suspected PCNSL (N = 1007 patients) and designed a rapid multiplexed genotyping assay for MYD88, TERT promoter, IDH1/2, H3F3A, and BRAF mutations to facilitate the diagnosis of PCNSL from CSF and detect other neoplasms in the differential diagnosis. Among 159 patients with confirmed PCNSL, the median time to secure a diagnosis of PCNSL was 10 days, with a range of 0 to 617 days. Permanent histopathology confirmed PCNSL in 142 of 152 biopsies (93.4%), whereas CSF analyses were diagnostic in only 15/113 samplings (13.3%). Among 86 archived clinical specimens, our targeted genotyping assay accurately detected hematologic malignancies with 57.6% sensitivity and 100% specificity (95% confidence interval [CI]: 44.1% to 70.4% and 87.2% to 100%, respectively). MYD88 and TERT promoter mutations were prospectively identified in DNA extracts of CSF obtained from patients with PCNSL and glioblastoma, respectively, within 80 minutes. Across 132 specimens, hallmark mutations indicating the presence of malignancy were detected with 65.8% sensitivity and 100% specificity (95% CI: 56.2%-74.5% and 83.9%-100%, respectively). This targeted genotyping approach offers a rapid, scalable adjunct to reduce diagnostic and treatment delays in PCNSL.

21 January 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ACAvilash K. Cramer
Avilash K. Cramer
DPDeborah Plana
Deborah Plana
HYHelen Yang
Helen Yang
MCMary M. Carmack
Mary M. Carmack
Enze TianEnze Tian
Enze Tian
NLNicole R. LeBoeuf
Nicole R. LeBoeuf
The COVID-19 pandemic has led to widespread shortages of personal protective equipment (PPE) for healthcare workers, including of N95 masks (filtering facepiece respirators; FFRs). These masks are intended for single use but their sterilization and subsequent reuse has the potential to substantially mitigate shortages. Here we investigate PPE sterilization using ionized hydrogen peroxide (iHP), generated by SteraMist equipment (TOMI; Frederick, MD), in a sealed environment chamber. The efficacy of sterilization by iHP was assessed using bacterial spores in biological indicator assemblies. After one or more iHP treatments, five models of N95 masks from three manufacturers were assessed for retention of function based on their ability to form an airtight seal (measured using a quantitative fit test) and filter aerosolized particles. Filtration testing was performed at a university lab and at a National Institute for Occupational Safety and Health (NIOSH) pre-certification laboratory. The data demonstrate that N95 masks sterilized using SteraMist iHP technology retain filtration efficiency up to ten cycles, the maximum number tested to date. A typical iHP environment chamber with a volume of ~ 80 m3 can treat ~ 7000 masks and other items (e.g. other PPE, iPADs), making this an effective approach for a busy medical center.

1 September 2025 in Journal of Applied Physiology
Verified
Journal Article
Closed access
ANAlice Nova
Alice Nova
YXYi Xin
Yi Xin
MVMarcus Victor
Marcus Victor
TGTimothy G. Gaulton
Timothy G. Gaulton
GAGlasiele C. Alcala
Glasiele C. Alcala
MCMaurizio Cereda
Maurizio Cereda
In a ventilated swine model, we isolated the mechanical effects of mass loading from those of lung injury. Despite optimization, positive end-expiratory pressure (PEEP) could not restore baseline pulmonary compliance or lung volumes in either healthy or injured lungs. Partitioned respiratory mechanics and imaging reveal that geometric constraints and load-induced airway closure, demonstrated here for the first time in injured swine, may limit the effectiveness of recruitment maneuvers and optimized PEEP in mass-loaded lungs.

5 September 2024 in Blood
Verified
Journal Article
Open access
PDF file
MGMihir Gupta
Mihir Gupta
JBJoseph D. Bradley
Joseph D. Bradley
EMElie Massaad
Elie Massaad
EBEvan J. Burns
Evan J. Burns
NGN. Zeke Georgantas
N. Zeke Georgantas
GSGanesh M. Shankar
Ganesh M. Shankar
Delays and risks associated with neurosurgical biopsies preclude timely diagnosis and treatment of central nervous system (CNS) lymphoma and other CNS neoplasms. We prospectively integrated targeted rapid genotyping of cerebrospinal fluid (CSF) into the evaluation of 70 patients with CNS lesions of unknown cause. Participants underwent genotyping of CSF-derived DNA using a quantitative polymerase chain reaction–based approach for parallel detection of single-nucleotide variants in the MYD88, TERT promoter, IDH1, IDH2, BRAF, and H3F3A genes within 80 minutes of sample acquisition. Canonical mutations were detected in 42% of patients with neoplasms, including cases of primary and secondary CNS lymphoma, glioblastoma, IDH-mutant brainstem glioma, and H3K27M-mutant diffuse midline glioma. Genotyping results eliminated the need for surgical biopsies in 7 of 33 cases (21.2%) of newly diagnosed neoplasms, resulting in significantly accelerated initiation of disease-directed treatment (median, 3 vs 12 days; P = .027). This assay was then implemented in a Clinical Laboratory Improvement Amendments environment, with 2-day median turnaround for diagnosis of CNS lymphoma from 66 patients across 4 clinical sites. Our study prospectively demonstrates that targeted rapid CSF genotyping influences oncologic management for suspected CNS tumors.